Samil Pharmaceutical's Non-Registered Executive Yoo Dam-hyang Buys 1,000 Shares at 7,490 KRW, Stake at 0.06%, Limited Shareholder Value Impact
Executive Vice President Yoo Dam-hyang purchased 1,000 common shares of Samil Pharmaceutical on June 1, 2026, at 7,490 KRW per share, increasing her holdings from 11,000 to 12,000 shares, representing 0.06% of total outstanding shares of 21,691,811.
Compared to the previous report (April 2023), the number of shares increased but the ownership ratio decreased from 0.07% to 0.06%, likely due to an increase in total shares outstanding.
This insider purchase is a small-scale transaction that may signal management confidence, but the tiny scale relative to market cap means it has no material impact on stock price or shareholder value.
[AI Summary]The purchase of 1,000 shares by executive Yoo Dam-hyang is too small to significantly affect the stock price. While insider buying is generally positive, the negligible transaction size makes it unlikely to alter market sentiment or price direction.
KOSPI Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders